Tamsulosin Hydrochloride Capsule
Product Images NDC 71335-0398

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71335-0398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350398)

This is a description for a medication called Tamsulosin HCI that comes in a package prepared by Bryant Ranch Prepach Burbank in California. The medication is in the form of an olive green and orange opaque capsule labeled as "0.4mg Capsule." The capsule packaging advises to keep all drugs out of reach of children and store at room temperature between 20-25°C (68-77°F). The medication is a generic equivalent of Flomax 0.4mg Capsule and has an NDC number of 7133503981. The expiration date is listed as MM/YY but is not provided in the text.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

The text is a figure description and does not provide enough information to generate a useful description.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

The text provides a graph (Figure 2B) indicating the mean change in the total AUA symptom score (0 to 35) for three treatments: O-0.08mg, LNt 0.4mg, and a placebo. The x-axis represents the duration of treatment (weeks), and the y-axis represents the mean change in total AUA symptom score. The graph shows the mean changes for different time points (0, 1, 2, 5, 9, 13, and LOCF). There is no non-English text.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

This text describes a figure labeled as "Figure 3B" which shows the mean increase in peak urine flow rate (measured in mL/Sec) for study 2. The x-axis of the figure represents the duration of treatment in weeks, while the y-axis represents the peak urine flow rate. The figure includes a line graph with a colored line indicating treatment and a grayscale line indicating no treatment. The figure also includes a legend indicating which line corresponds to which treatment.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.